Journal list Promote Sponsor
Clinical Research and Regulatory Affairs
United States · Informa Healthcare
workspace_premium Q2 — Pharmacology lock Subscription

Clinical Research and Regulatory Affairs

Clinical Research and Regulatory Affairs is a journal indexed in SJR in Pharmacology and Pharmaceutical Science with an H index of 16. It has a best quartile of Q2. It is published in English.

ISSN: 1060-1333
Publisher: Informa Healthcare
Category: Pharmacology
open_in_new Portal NPD menu_book Guidelines NPD
schedule CountryOfPapers database fields
SJR Impact Factor trending_up
NPD Q2
H-index 16
Acceptance rate pie_chart
44%
Source Acceptance_Rate
Time to publication hourglass_top
NPD
Field NPD
Publication cost (APC) payments
NPD Subscription
Non-OA path NPD

Metrics

Scimago and CountryOfPapers database fields

SJR Impact

—

H-index

16

Docs (year)

0

Docs 3y

8

Total refs

0

Cites 3y

6

Citable 3y

7

Cites/Doc 2y

0

Ref/Doc

0.0

Immediate OA

—

Embargoed OA

NPD

Non OA / Submission

—

shield Researcher voice

Name good journals. Call out predatory ones.

Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.

Fair & fast peer review Clear APC / no surprise fees Suspected predatory Fake impact claims
rate_review Write an honest review

Researcher reviews

sentiment_dissatisfied No reviews yet — be the first to share an honest experience.
User
* Only to validate authenticity — identity is not shown publicly.

Best articles by citations

Clinical trial design methodologies for advanced sarcoma therapy

View more

What Is the "Best" Approach for Measuring Service Quality of Periodontists?

View more

E-REGULATION AND INTERNET PHARMACIES: ISSUES AND DILEMMAS

View more

E-Commerce in Healthcare and Pharmaceutical Marketing - Opportunities and Concerns

View more

DRUG DEVELOPMENT TEAMS*

View more

Development and full validation of a quantitative assay for the determination of valsartan in human plasma and its application for bioequivalence study

View more

Determination of the Efficiency of First Time-In-Man Designs in Healthy Volunteers

View more

COULD PUBLICATION OF BIOINEQUIVALENCE DATA DISCOURAGE FRAUDS ON BIOEQUIVALENCE TRIALS?

View more

Considerations for clinical trial design with obesity-related devices

View more

CONSEQUENCES OF AN OUTPATIENT PHARMACY CLOSURE WITHIN AN ACADEMIC HEALTH CENTER

View more

Comparison of pharmacokinetics of citalopram in healthy Asian Indian and Mexican volunteers

View more

Comparison of effect of fasting and of five different diets on the bioavailability of single oral dose of clarithromycin 500mg extended release tablet

View more
SHOW MORE ARTICLES

Combinatorial Chemistry in the Drug Discovery Process

View more

A Concise View of Risk Management for Agrosecurity

View more

Child Birth Education for Adolescents: Removing the Barriers That Prevent Attendance at Child Birth Classes

View more

Can Rural Telemedicine Help to Solve the Health Care Access Problems in Turkey?

View more

BUILDING THE PILLARS OF DIVERSITY IN THE U.S. HEALTH SYSTEM: ADDRESSING DISPARITIES OF SEXUAL ORIENTATION AND GENDER IDENTITY

View more

Bioequivalence studies in Europe before and after 2010

View more

Attitudes and Opinions Towards Regulatory Aspects of Non-prescription Medicines

View more

AN ASSESSMENT OF QUALITY OF LIFE IN AMBULATORY SCHIZOPHRENICS: WORLD HEALTH ORGANIZATION QUALITY OF LIFE ASSESSMENT SCALE (WHOQOL-100) CONCEPTS QUALITY OF LIFE OF AMBULATORY SCHIZOPHRENICS

View more

Adaptive designs for comparative effectiveness research trials

View more

A Rational Approach to Drug Development: The Exploratory Phase

View more

A Practical Guide on Incorporating and Evaluating Patient-Reported Outcomes in Clinical Trials

View more

A New Suggestion for the Classification of Missing Values in the Outcome of Clinical Trials

View more

FAQs